出处
《人民军医》
2005年第4期231-233,共3页
People's Military Surgeon
基金
国家高技术研究发展计划(863计划)组织工程皮肤重大专项(2002AA205041
负责人:金岩)
参考文献17
-
1Henna Vihola,Antti Laukkanen,Jouni Hirvonen et al.Binding and release of drugs into and from thermosensitive poly(N-vinylcaprolactam) nanoparticles.European Journal of Pharmaceutical Sciences ,2002,16(1):69
-
2Huang G,Gao J,Hu ZB et al.Controlled drug release from hydrogel nanoparticle networks.J Control Release,2004.94 (3):303
-
3Kumaresh S.Soppimath,Tejraj M et al.Biodegradable polymeric nanoparticles as drug delivery device.J Control Release,2001,70 (1):1
-
4Lin-Shu Liu,Andrea Y,Thompson A et al.An osteoconductive collagen/hyaluronate matrix for bone regeneration.Biomaterials,1999,20(12):1 097
-
5Hasan Uludag,Paul De Vos and Patrick A.Technology of mammalian cell encapsulation?.Adv Drug Deliv Rev,2000,42(1):29
-
6Stenekes RJ,Talsma H,Hennink WE.Formation of dextran hydrogels by crystallization.Biomaterials,2001,22(13):1 891
-
7de Jong SJ,van Eerdenbrugh B,van Nostrum CF.Physically crosslinked dextran hydrogels by stereocomplex formation of lactic acid oligomers:degradation and protein release behavior.J Control Release,2001 ,71(3):261
-
8Stenekes RJ,Franssen O,van Bommel EM et al.The preparation of dextran microspheres in an all-aqueous system:effect of the formulation parameters on particle characteristics.Pharm Res,1998,15(4):557
-
9Stenekes RJ,De Smedt SC,Demeester J et al.Pore sizes in hydrated dextran microspheres.Biomacromolecules,2000,1(4):696
-
10Seppas NA,Bures P,Leobandung W et al.Hydrogels in pharmaceutical formulations?.European Journal of Pharmaceutical Biopharmaceutics,2000,50(1):27
二级参考文献26
-
1Holland TA,Tessmar JK,Tabata Y,et al.Transforming growth factor-beta1 release from oligo[poly(ethylene glycol) fumarate] hydrogels in conditions that model the cartilage wound healing environment.J Control Release,2004,94:101-114.
-
2Nakashima M,Reddi AH.The application of bone morphogenetic proteins to dental tissue engineering.Nat Biotechnol,2003,21:1025-1032.
-
3Pini Prato GP, Rotundo R, Magnani C, et al. Tissue engineering technology for gingival augmentation procedures: a case report. Int J Periodontics Restorative Dent, 2000,20:552-559.
-
4Camelo M, Nevins ML, Schenk RK, et al. Periodontal regeneration in human Class Ⅱ furcations using purified recombinant human platelet-derived growth factor-BB (rhPDGF-BB) with bone allograft. Int J Periodontics Restorative Dent,2003,23:213-225.
-
5Taira M, Nakao H, Takahashi J, et al. Effects of two vitamins, two growth factors and dexamethasone on the proliferation of rat bone marrow stromal cells and osteoblastic MC3T3-E1 cells. J Oral Rehabil,2003,30:697-701.
-
6Zhao M, Jin Q, Berry JE, et al.Cementoblast delivery for periodontal tissue engineering. J Periodontol,2004,75:154-161.
-
7Anusaksathien O, Giannobile WV. Growth factor delivery to re-engineer periodontal tissues. Curr Pharm Biotechnol,2002,3:129-139.
-
8Takayama S, Murakami S, Shimabukuro Y, et al. Periodontal regeneration by FGF-2 (bFGF) in primate models. J Dent Res, 2001, 80:2075-2079.
-
9Rossa C Jr, Marcantonio E Jr, Cirelli JA, et al. Regeneration of Class Ⅲ furcation defects with basic fibroblast growth factor (b-FGF) associated with GTR. A descriptive and histometric study in dogs. J Periodontol, 2000, 71:775-784.
-
10Nakahara T, Nakamura T, Kobayashi E, et al. Novel approach to regeneration of periodontal tissues based on in situ tissue engineering: effects of controlled release of basic fibroblast growth factor from a sandwich membrane. Tissue Eng,2003,9:153-162.
共引文献27
-
1陈发明,吴织芬,金岩.引导牙周组织再生在伴牙槽骨缺损牙再植术中应用的回顾性研究[J].口腔医学研究,2004,20(5):501-503. 被引量:7
-
2陈发明,吴织芬,金岩,王勤涛,王国芳,杜岩,黄沙.复合重组人骨形态发生蛋白-2缓释微球的引导组织再生膜的制备[J].牙体牙髓牙周病学杂志,2005,15(3):140-143. 被引量:4
-
3孙海花,薛蓓蕾,刘海燕,陈发明.牙撕脱的辅助治疗方法[J].牙体牙髓牙周病学杂志,2005,15(2):110-113. 被引量:2
-
4陈发明,吴织芬,金岩,王勤涛,吴红,王国芳,杜岩,黄沙,姜瑜.载rhBMP2凝胶微球控释系统的设计与合成实验[J].实用口腔医学杂志,2005,21(2):174-177. 被引量:10
-
5陈发明,吴织芬,金岩,王勤涛,姜玲,杜岩,王国芳.rhBMP_2缓释微球对牙龈成纤维细胞的生物学作用[J].口腔医学研究,2005,21(3):236-239. 被引量:1
-
6贾保军,吕新海,陈发明,常书楼.羟基磷灰石与生物膜合用于自体埋伏牙移植15例报告[J].牙体牙髓牙周病学杂志,2005,15(8):451-453. 被引量:6
-
7陈发明,金岩,吴织芬,杜岩,王国芳,吴红.重组人骨形态发生蛋白-2缓释凝胶微球的研制及其溶胀、降解、载药、释药特征[J].中华创伤杂志,2005,21(9):697-701. 被引量:3
-
8陈发明,吴织芬,金岩,吴红.右旋糖酐基水凝胶药物控释体系的应用研究[J].中国修复重建外科杂志,2005,19(11):919-922. 被引量:4
-
9陈发明,吴织芬,金岩,王勤涛,杜岩,王国芳.rhBMP_2纳米缓释系统的制备及其对骨髓间充质干细胞增殖和分化的影响[J].上海口腔医学,2005,14(5):485-489. 被引量:3
-
10陈发明,吴织芬,金岩,吴红,杜岩,王国芳,聂鑫.釉基质蛋白控释微球的研制及其生物学性能的初步研究[J].华西口腔医学杂志,2005,23(6):529-533. 被引量:7
同被引文献3
-
1王云普,袁昆,李全莲,顾生玖.可生物降解的pH敏感水凝胶的合成及其溶胀性能研究[J].功能高分子学报,2004,17(4):586-590. 被引量:8
-
2胡卫岚,陈晓明,李湘南.骨组织工程材料β-磷酸三钙及其复合材料改性的研究进展[J].生物骨科材料与临床研究,2008,5(4):43-47. 被引量:7
-
3郭玉明,张秀英,蒋凯,建国,胡志国,杨小丽,杨林.高分子基质作用下碳酸钙的仿生合成[J].化学学报,2001,59(5):755-762. 被引量:30
-
1陈智,樊明文,凌均启,罗雯.氯乙啶控释系统的体外抑菌作用[J].牙体牙髓牙周病学杂志,1992,2(4):234-235.
-
2孙廷禹,张学臻.药物控释系统与钙通道阻滞剂[J].临床荟萃,1996,11(14):630-631.
-
3陈华春.生物降解高分子聚合物药物控释系统[J].中国医药工业杂志,1992,23(2):86-89. 被引量:1
-
4邹艳霜,孙淑英.脂质体和服用喹诺酮的方法[J].辽宁医药,2001,16(3):33-34.
-
5赵宝成,袁天祥,马宝通.丝素蛋白药物控释系统研究进展[J].中国骨与关节外科,2013,6(2):195-198.
-
6王希鼎.粉尘及其危害[J].玻璃,1997,24(2):38-40. 被引量:6
-
7李肖屹,尹蓉莉,钟玲,李君富,罗燕.人参总皂苷渗透泵片制备及体外释放度考察[J].医学研究杂志,2009,38(1):66-68. 被引量:2
-
8赛那,顾艳丽,张微,李君,金蓉.阿替洛尔缓释微囊载药量的测定及体外释放行为研究[J].中南药学,2012,10(1):30-32. 被引量:5
-
9凌均启,樊明文,彭彬,罗雯,贺红.根管消毒药物控释系统的体外细胞霉性研究[J].口腔医学纵横,1994,10(3):138-140. 被引量:5
-
10裴勇,张悦.可降解纳米材料在药物控释系统中的应用[J].株洲师范高等专科学校学报,2004,9(2):17-20. 被引量:2